Compare ETFs: HELX

HELX

Comparison

Symbol	Company Name	Stock Price	% Change	Assets	Exp. Ratio	PE Ratio	Div. Yield
HELX	Franklin Genomic Advancements ETF	37.35	-1.86%	22.84M	0.50%	33.21	-

Symbol	Year-to-date	1 Year	5 Years	10 Years	Inception
HELX	29.32%	20.31%	-1.38%	-	7.95%

HELX - Franklin Genomic Advancements ETF
No.	Symbol	Name	Weight
1	GH	Guardant Health, Inc.	6.83%
2	NTRA	Natera, Inc.	6.82%
3	INSM	Insmed Incorporated	4.89%
4	MEDP	Medpace Holdings, Inc.	4.53%
5	KRYS	Krystal Biotech, Inc.	3.90%
6	ALNY	Alnylam Pharmaceuticals, Inc.	3.85%
7	ADPT	Adaptive Biotechnologies Corporation	3.84%
8	BBIO	BridgeBio Pharma, Inc.	3.45%
9	UTHR	United Therapeutics Corporation	3.31%
10	LGND	Ligand Pharmaceuticals Incorporated	3.16%
11	KRX: 207940	Samsung Biologics Co.,Ltd.	2.96%
12	TEM	Tempus AI, Inc.	2.87%
13	AZN	AstraZeneca PLC	2.70%
14	LLY	Eli Lilly and Company	2.64%
15	VRTX	Vertex Pharmaceuticals Incorporated	2.50%
16	WGS	GeneDx Holdings Corp.	2.50%
17	REGN	Regeneron Pharmaceuticals, Inc.	2.29%
18	EXAS	Exact Sciences Corporation	2.16%
19	IONS	Ionis Pharmaceuticals, Inc.	1.99%
20	CTVA	Corteva, Inc.	1.86%
21	GRAL	GRAIL, Inc.	1.84%
22	BNTX	BioNTech SE	1.80%
23	EBR: ARGX	argenx SE	1.71%
24	PTCT	PTC Therapeutics, Inc.	1.62%
25	TVTX	Travere Therapeutics, Inc.	1.48%
View HELX holdings